Jeffrey Eisenberg
Net worth: 1 575 $ as of 2024-04-29
Profile
Jeffrey F.
Eisenberg served as President, Chief Executive Officer & Director at Noven Pharmaceuticals, Inc. from 2009 to 2016.
He then became Chief Executive Officer & Director at Xenetic Biosciences, Inc. from 2017 to 2024.
Additionally, he was an Independent Director at MabVax Therapeutics Holdings, Inc. from 2016 to 2018.
Prior to these roles, he worked as Associate General Counsel at IVAX LLC from 1995 to 1998.
He also served as President at Novogyne Pharmaceuticals from 2007 to 2014.
Mr. Eisenberg holds a graduate degree from Columbia Law School and an undergraduate degree from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-30 | 417 ( 0.03% ) | 1 575 $ | 2024-04-29 |
Former positions of Jeffrey Eisenberg
| Companies | Position | End |
|---|---|---|
| XENETIC BIOSCIENCES, INC. | Chief Executive Officer | 2024-05-15 |
| MABVAX THERAPEUTICS HOLDINGS, INC. | Director/Board Member | 2018-07-30 |
Noven Pharmaceuticals, Inc.
 Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Chief Executive Officer | 2015-12-31 |
Novogyne Pharmaceuticals
 Novogyne Pharmaceuticals Pharmaceuticals: MajorHealth Technology Novogyne Pharmaceuticals manufactures pharmaceutical products. | President | 2014-07-31 |
IVAX LLC
 IVAX LLC Pharmaceuticals: MajorHealth Technology IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1987 and is headquartered in Weston, FL. | General Counsel | - |
Training of Jeffrey Eisenberg
| Columbia Law School | Graduate Degree |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| XENETIC BIOSCIENCES, INC. | Health Technology |
| Private companies | 6 |
|---|---|
IVAX LLC
IVAX LLC Pharmaceuticals: MajorHealth Technology IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1987 and is headquartered in Weston, FL. | Health Technology |
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Health Technology |
MabVax Therapeutics, Inc.
 MabVax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology MabVax Therapeutics, Inc. developed and commercialized immunotherapeutics for the treatment of cancer. The company was founded in 2006 and is headquartered in San Diego, CA. | Health Technology |
Steel Hector & Davis LLP
 Steel Hector & Davis LLP Miscellaneous Commercial ServicesCommercial Services Part of Squire Patton Boggs (US) LLP, Steel Hector & Davis LLP provides legal services. The company is based in Miami, FL. Steel Hector & Davis was acquired by Squire Sanders (US) LLP on September 06, 2005. | Commercial Services |
MabVax Therapeutics Holdings, Inc.
 MabVax Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA. | Health Technology |
Novogyne Pharmaceuticals
Novogyne Pharmaceuticals Pharmaceuticals: MajorHealth Technology Novogyne Pharmaceuticals manufactures pharmaceutical products. | Health Technology |
- Stock Market
- Insiders
- Jeffrey Eisenberg
